Co-Diagnostics, Inc. (CODX)
1.09
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 11:04
Co-Diagnostics Gross Profit Margin (Quarterly) : -48.77% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -48.77% |
| March 31, 2026 | -207.7% |
| December 31, 2025 | -587.8% |
| September 30, 2025 | -102.0% |
| June 30, 2025 | -98.59% |
| March 31, 2025 | -500.6% |
| December 31, 2024 | -310.0% |
| September 30, 2024 | -213.5% |
| June 30, 2024 | -241.7% |
| March 31, 2024 | -123.6% |
| December 31, 2023 | 7.72% |
| September 30, 2023 | 77.53% |
| June 30, 2023 | -286.4% |
| March 31, 2023 | -35.93% |
| December 31, 2022 | 41.89% |
| September 30, 2022 | 78.79% |
| June 30, 2022 | 73.33% |
| March 31, 2022 | 84.45% |
| December 31, 2021 | 87.31% |
| September 30, 2021 | 88.69% |
| June 30, 2021 | 90.58% |
| March 31, 2021 | 83.32% |
| Date | Value |
|---|---|
| December 31, 2020 | 83.90% |
| September 30, 2020 | 73.16% |
| June 30, 2020 | 75.04% |
| March 31, 2020 | 67.55% |
| December 31, 2019 | 33.70% |
| September 30, 2019 | 9.90% |
| June 30, 2019 | 10.88% |
| March 31, 2019 | -314.7% |
| December 31, 2018 | -108.3% |
| September 30, 2018 | -29.90% |
| June 30, 2018 | -29.90% |
| March 31, 2018 | -27.84% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | -376.9% |
| June 30, 2017 | -356.0% |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -38.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Fractyl Health, Inc. | -- |
| Spectral AI, Inc. | 31.58% |
| Quantum-Si, Inc. | -298.8% |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
| Omnicell, Inc. | 48.98% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -180.5% |
| Return on Assets | -150.4% |
| Return on Invested Capital | -169.8% |
| Profit Margin (Quarterly) | -3.78K% |
| Operating Margin (Quarterly) | -3.73K% |
| Return on Net Operating Assets | -237.1% |